Dicot develops drugs against sexual dysfunction with a large market potential

Dicot develops drugs against sexual dysfunction with a large market potential

Dicot's most important product is Libiguin™ for the treatment of erectile dysfunction and premature ejaculation among men, as well as potentially for the treatment of decreased lust. The origin of Libiguin™ is a substance that comes from a plant used in folk medicine for treatment of reduced sexual ability.

Dicot has developed and patented methods for manufacturing of Libiguin™ through a semisynthetic method that does not rely on any supply of materials from the original plant, thus securing a sustainable and environmental friendly production of the substance.

Dicot also has patented the Libiguin™ substance itself.

In pre-clinical tests, Libiguin™ has shown effects in very low doses, giving a remarkable long-lasting effect. The long-lasting effect eliminates the need for pre-planning to take medication before sexual activity, which is generally the case with current treatments.

More news